Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I
- PMID: 1496008
- PMCID: PMC49660
- DOI: 10.1073/pnas.89.15.7134
Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I
Abstract
Atherosclerosis is a major cause of morbidity and mortality in developed countries. In humans the risk of atherosclerosis is inversely correlated with plasma levels of high density lipoprotein (HDL). As a step in determining whether the experimental reduction of plasma HDL level will increase susceptibility to atherosclerosis, we have used gene targeting in embryonic stem cells to produce mice lacking apolipoprotein A-I, the major protein component of HDL particles. Mice homozygous for the disrupted gene have no plasma apolipoprotein A-I detectable by double immunodiffusion; their total plasma cholesterol and HDL-cholesterol levels after overnight fasting are reduced to about one-third and one-fifth of normal levels, and they are grossly deficient in alpha-migrating HDL particles.
Similar articles
-
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.Arterioscler Thromb. 1993 Dec;13(12):1814-21. doi: 10.1161/01.atv.13.12.1814. Arterioscler Thromb. 1993. PMID: 8241102
-
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I.Transgenic Res. 1992 May;1(3):142-7. doi: 10.1007/BF02528779. Transgenic Res. 1992. PMID: 1301210
-
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9322-7. doi: 10.1073/pnas.96.16.9322. Proc Natl Acad Sci U S A. 1999. PMID: 10430941 Free PMC article.
-
[Apolipoprotein A I-C III-A IV deficiency].Nihon Rinsho. 1994 Dec;52(12):3253-6. Nihon Rinsho. 1994. PMID: 7853719 Review. Japanese.
-
Transgenic mouse models of lipoprotein metabolism and atherosclerosis.Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8314-8. doi: 10.1073/pnas.90.18.8314. Proc Natl Acad Sci U S A. 1993. PMID: 8378301 Free PMC article. Review.
Cited by
-
Absence of apolipoprotein E protects mice from cerebral malaria.Sci Rep. 2016 Sep 20;6:33615. doi: 10.1038/srep33615. Sci Rep. 2016. PMID: 27647324 Free PMC article.
-
Molecular regulation of HDL metabolism and function: implications for novel therapies.J Clin Invest. 2006 Dec;116(12):3090-100. doi: 10.1172/JCI30163. J Clin Invest. 2006. PMID: 17143322 Free PMC article. Review.
-
Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism.Diabetologia. 2007 Sep;50(9):1960-1968. doi: 10.1007/s00125-007-0752-7. Epub 2007 Jul 18. Diabetologia. 2007. PMID: 17639303
-
High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.Circulation. 2010 Nov 9;122(19):1919-27. doi: 10.1161/CIRCULATIONAHA.110.961193. Epub 2010 Oct 25. Circulation. 2010. PMID: 20974999 Free PMC article.
-
Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.Biochem J. 2007 Aug 15;406(1):167-74. doi: 10.1042/BJ20070296. Biochem J. 2007. PMID: 17506726 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials